A total of 686 patients ( polymer-free sirolimus-eluting stents , n = 345 vs polymer-based paclitaxel-eluting stents , n = 341 ) and 751 lesions ( polymer-free sirolimus-eluting stents , n = 383 vs polymer-based paclitaxel-eluting stents , n = 368 ) were included in the study .